Girdin Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-76253
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot, ELISA, Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
1 mg/ml
Product Specifications
Immunogen
Antibody was raised against a 16 amino acid synthetic peptide from near the carboxy terminus human Girdin. The immunogen is located within the last 50 amino acids of Girdin.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Girdin Antibody - BSA Free
Western Blot: Girdin AntibodyBSA Free [NBP1-76253]
Western Blot: Girdin Antibody [NBP1-76253] - Rat brain tissue lysate with Girdin antibody at (A) 1 and (B) 2 ug/mL.Immunocytochemistry/ Immunofluorescence: Girdin Antibody - BSA Free [NBP1-76253] -
Immunocytochemistry/ Immunofluorescence: Girdin Antibody - BSA Free [NBP1-76253] - Immunofluorescence of Girdin in human brain tissue with Girdin antibody at 20 u/mL.Applications for Girdin Antibody - BSA Free
Application
Recommended Usage
ELISA
1:100-1:2000
Immunocytochemistry/ Immunofluorescence
20 ug/mL
Western Blot
1-2 ug/ml
Formulation, Preparation, and Storage
Purification
Peptide affinity purified
Formulation
PBS
Format
BSA Free
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Girdin
Long Name
Girders of Actin Filament
Alternate Names
APE, CCDC88A, GIV, GRDN, HkRP1
Gene Symbol
CCDC88A
UniProt
Additional Girdin Products
Product Documents for Girdin Antibody - BSA Free
Product Specific Notices for Girdin Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...